MX2018001002A - Composiciones y formulaciones antimicrobianas. - Google Patents

Composiciones y formulaciones antimicrobianas.

Info

Publication number
MX2018001002A
MX2018001002A MX2018001002A MX2018001002A MX2018001002A MX 2018001002 A MX2018001002 A MX 2018001002A MX 2018001002 A MX2018001002 A MX 2018001002A MX 2018001002 A MX2018001002 A MX 2018001002A MX 2018001002 A MX2018001002 A MX 2018001002A
Authority
MX
Mexico
Prior art keywords
hydrogen peroxide
compositions
phase
antimicrobial compositions
releasing hydrogen
Prior art date
Application number
MX2018001002A
Other languages
English (en)
Inventor
Constance Cox Sophie
Jon Hall Thomas
Michael Grover Liam
Salib Rami
Patton Thomas
Brennan James
Reginald Barrett John
Staples Ian
Original Assignee
Matoke Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1513045.3A external-priority patent/GB201513045D0/en
Application filed by Matoke Holdings Ltd filed Critical Matoke Holdings Ltd
Publication of MX2018001002A publication Critical patent/MX2018001002A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)

Abstract

Se describen composiciones para generar actividad antimicrobiana. Las composiciones comprende: una primera fase; una segunda fase; una enzima que es capaz de convertirse a un sustrato para liberar peróxido de hidrógeno; y una sustancia que incluye un sustrato para la enzima, en donde la primera fase y la segunda fase no son miscibles. Las composiciones pueden formularse como coloides, suspensiones o emulsiones, especialmente como cremas o rocíos. Se describen métodos para hacer las composiciones, así como su uso para el tratamiento de infecciones microbianas.
MX2018001002A 2015-07-23 2016-07-22 Composiciones y formulaciones antimicrobianas. MX2018001002A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1513045.3A GB201513045D0 (en) 2015-07-23 2015-07-23 Antimicrobial compositions and formulations
GB201606249 2016-04-12
PCT/GB2016/052258 WO2017013448A1 (en) 2015-07-23 2016-07-22 Antimicrobial compositions and formulations releasing hydrogen peroxide

Publications (1)

Publication Number Publication Date
MX2018001002A true MX2018001002A (es) 2018-09-28

Family

ID=56555490

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001002A MX2018001002A (es) 2015-07-23 2016-07-22 Composiciones y formulaciones antimicrobianas.

Country Status (16)

Country Link
US (1) US20180318399A1 (es)
EP (1) EP3324998A1 (es)
JP (1) JP2018527320A (es)
KR (1) KR20180051501A (es)
CN (1) CN107847566A (es)
AU (1) AU2016296150A1 (es)
BR (1) BR112018001279A2 (es)
CA (1) CA2990326A1 (es)
CO (1) CO2018001628A2 (es)
GB (1) GB2556567A (es)
HK (1) HK1256251A1 (es)
MA (1) MA42910A (es)
MX (1) MX2018001002A (es)
PH (1) PH12018500374A1 (es)
RU (1) RU2018105622A (es)
WO (1) WO2017013448A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3245871A1 (en) 2014-04-30 2017-11-22 Matoke Holdings Limited Antimicrobial compositions
WO2018065789A1 (en) * 2016-10-06 2018-04-12 Matoke Holdings Limited Antimicrobial compositions
WO2018091890A1 (en) * 2016-11-15 2018-05-24 Matoke Holdings Limited Antimicrobial compositions and formulations
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
WO2019077336A1 (en) * 2017-10-16 2019-04-25 Matoke Holdings Limited DOUBLE DISTRIBUTOR CONTAINING WATER AND ANTIMICROBIAL COMPOSITION
CN107668320A (zh) * 2017-11-03 2018-02-09 杭州市农业科学研究院 以蜂蜜为原料的饲料添加剂及其制备方法
WO2020022989A2 (en) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Topical compositions for baby skin care
CN110734563B (zh) * 2018-07-20 2022-05-17 南京理工大学 细菌纤维素/鸸鹋油复合膜及其制备方法
EP3946481A2 (en) 2019-03-27 2022-02-09 Matoke Holdings Limited Antimicrobial compositions
CN111631271A (zh) * 2020-05-22 2020-09-08 南昌大学 一种稳定w/o/w型多重乳液的制备方法
WO2023227599A1 (en) * 2022-05-23 2023-11-30 Atlantic Technological University Antimicrobial coating composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
US5980875A (en) * 1996-04-12 1999-11-09 Mousa; Mahmoud A. Honey preparations
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
FR2769504B1 (fr) * 1997-10-13 2000-03-10 Oreal Utilisation du miel en tant qu'agent diminuant l'adhesion des micro-organismes
NL1017333C2 (nl) * 2001-02-12 2002-08-13 Gent Natural Products Van Cosmetisch resp. farmaceutisch preparaat.
AU2003234758B2 (en) * 2002-08-13 2009-04-02 Derma Sciences, Inc. Composition
BE1017155A3 (nl) * 2006-06-01 2008-03-04 Sanomedical Bvba Wondverzorgingsproduct.
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
DE102008034944B4 (de) * 2008-07-26 2017-03-16 Arivine Pharma Ag Mikroemulsion
JP5750404B2 (ja) * 2012-06-14 2015-07-22 株式会社山田蜂蜜研究所 抗菌剤及び化粧料

Also Published As

Publication number Publication date
PH12018500374A1 (en) 2018-08-20
US20180318399A1 (en) 2018-11-08
CA2990326A1 (en) 2017-01-26
RU2018105622A3 (es) 2020-02-21
BR112018001279A2 (pt) 2018-09-11
HK1256251A1 (zh) 2019-09-20
MA42910A (fr) 2018-05-30
WO2017013448A1 (en) 2017-01-26
GB201801667D0 (en) 2018-03-21
CN107847566A (zh) 2018-03-27
JP2018527320A (ja) 2018-09-20
EP3324998A1 (en) 2018-05-30
RU2018105622A (ru) 2019-08-27
KR20180051501A (ko) 2018-05-16
AU2016296150A1 (en) 2018-03-01
GB2556567A (en) 2018-05-30
CO2018001628A2 (es) 2018-11-22

Similar Documents

Publication Publication Date Title
PH12018500374A1 (en) Antimicrobial compositions and formulations releasing hydrogen peroxide
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2019003735A (es) Formulaciones diluibles de cannabinoides y procesos para su preparacion.
PH12017501191B1 (en) Quinazoline derivatives used to treat hiv
MX2017010411A (es) Plataforma de produccion quimica flexible.
AU2017228405A8 (en) Small molecule IRE1-alpha inhibitors
GB2550301A (en) Antimicrobial fibers and compositions
MX2019015744A (es) Composiciones farmaceuticas.
TN2018000424A1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
WO2016083798A8 (en) Prevention and treatment of microbial infections
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
ZA201805792B (en) Taurine and aloe synergistic anti-irritant compositions and methods
EP3463277A4 (en) FORMULATIONS FOR SUBSTITUTED 3-PYRROLIDINES, COMPOSITIONS THEREFOR AND USES THEREOF
MY192425A (en) Polymorphs
PH12017501692A1 (en) Solid forms of menaquinols
CR20200275A (es) Hidroxiisoxazolinas y derivados de estos
MX360084B (es) Composicion de champu que comprende matriz de gel e histidina.
NZ732529A (en) Microencapsulated nitrification inhibitor compositions
MX2019007105A (es) Composiciones para el cuidado bucal y metodos para mejorar la estabilidad de estas.
MX2017009289A (es) Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas.
MX2019011613A (es) Formulaciones de acido 1-amino-1-ciclopropanocarboxilico.
TN2018000297A1 (en) (en) solvent-free formulations of low-melting active substances.
MX368268B (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih).
MX2018002859A (es) Extracto de gardenia para colorear la piel.
EA032472B9 (ru) Композиция для укладки волос